Therefore, this study employs genetic engineering techniques to construct an EpCAM overexpression vector and a CRISPR/Cas9 knockdown vector, while also establishing colorectal cancer cell lines with EpCAM overexpression as well as downregulated or knocked down EpCAM. The gene discussed is EPCAM; the disease is colorectal cancer.